Conclusion
In symptomatic AF patients, the effectiveness of an active rhythm
control strategy has been emphasized. However, rhythm control strategy
in patients with AF who have SVR should be undertaken with caution.
Careful patient selection based on the pathogenesis of AF and
risk-benefit assessment may be crucial. Further prospective and
large-scale randomized studies on rhythm control strategies for patients
with AF and SVR are required.